Stock EPIX ESSA PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus ESSA Pharma Inc.

Equities

EPIX

CA29668H7085

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
6.08 USD -0.65% Intraday chart for ESSA Pharma Inc. -3.80% -7.88%
Mar. 06 Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call
Mar. 06 Norway's wealth fund pushes for more women on emerging market company boards RE

Evolution of the average Target Price on ESSA Pharma Inc.

Price target over the last 5 years

History of analyst recommendation changes

b7d.YrzQ-EIP4eKDHV2XyJCk5qYHpXJZc0cTIznZ0qsudBg.NYuYunNp2a_TKDftpunIoM5-4AhhIzF2Dlywu8hZIShR0LuZLmKqh_ZxFA~18bcf9687a0fb5dd75207f5f7ae1d9cc

Analyst Recommendations on ESSA Pharma Inc.

Oppenheimer Adjusts ESSA Pharma's Price Target to $17 From $23, Maintains Outperform Rating MT
Oppenheimer Adjusts ESSA Pharma Price Target to $23 From $22, Maintains Outperform Rating MT
Piper Sandler Adjusts ESSA Pharma's Price Target to $20 From $50, Reiterates Overweight Rating MT
ESSA PHARMA : Oppenheimer Adjusts ESSA Pharma PT to $22 From $36 on Delayed EPI-7386 Clinical Update, Maintains Outperform Rating MT
ESSA PHARMA : Piper Sandler Starts ESSA Pharma at Overweight With $50 Price Target MT
ESSA PHARMA : HC Wainwright Adjusts ESSA Pharma PT to $32 From $36, Maintains Buy Rating MT
ESSA PHARMA : Oppenheimer Adjusts ESSA Pharma PT to $36 From $20, Maintains Outperform Rating MT
ESSA PHARMA : HC Wainwright & Co. Adjusts Price Target on ESSA Pharma to $36 From $17, Maintains Buy Rating MT
ESSA PHARMA : Oppenheimer Adjusts ESSA Pharma PT to $20 From $9, Maintains Outperform Rating MT
ESSA PHARMA : Jefferies Starts ESSA Pharma at Buy With $17 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
8.323 CAD
Average target price
27.08 CAD
Spread / Average Target
+225.34%
High Price Target
39.08 CAD
Spread / Highest target
+369.51%
Low Price Target
20.16 CAD
Spread / Lowest Target
+142.21%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ESSA Pharma Inc.

Oppenheimer
Piper Sandler
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EPIX Stock
  4. Consensus ESSA Pharma Inc.